Symbol
Editas Medicine, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.18
Current price of the stock
$2M
Trading volume of the stock
$97.3M
Market capitalization of the company
Micro Cap
Category of market capitalization
45.35%
Long-term growth mean estimate
3.36
Mean analyst rating
228.39%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.75
Current ratio
100.00%
Gross profit margin
-107649.20%
Operating profit margin
-107649.20%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-101870.50%
Pretax profit margin
-101870.50%
Net profit margin
-35.38%
Measures profitability relative to shareholders' equity
-35.38%
ROE excluding intangible assets
-18.97%
Measures profitability relative to total assets
-35.38%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
0.48
Receivables turnover ratio
185.90
Average number of days it takes to collect receivables
-0.47
Measures valuation relative to earnings
-0.65
P/E based on future earnings estimates
1.58
Measures valuation relative to sales
0.55
Measures valuation relative to book value
-0.21
Measures valuation relative to operating cash flow
-0.20
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
